BAJAJ BROKING

Notification close image
No new Notification messages
card image
Accretion Pharmaceuticals IPO is Open!
Apply for the Accretion Pharmaceuticals IPO through UPI in just minutes.
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Accretion Pharmaceuticals IPO Live Subscription Status

As of today, May 9, 2025, the Accretion Pharmaceuticals IPO is scheduled to open for subscription from May 14 to May 16, 2025. Currently, there is no live subscription data available, as the IPO has not yet commenced. Investors interested in participating can prepare by reviewing the IPO details and ensuring their brokerage accounts are set up for application.

Once the IPO opens, live subscription status updates will be available through official channels such as the NSE SME platform and the registrar's website. These updates will provide real-time information on the subscription levels across various investor categories, including Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs). Monitoring these figures can offer insights into investor demand and market sentiment during the subscription period. For more details, visit the Accretion Pharmaceuticals IPO page.

Subscription Status of Accretion Pharmaceuticals IPO (Day Wise)

The IPO subscription number shows how much demand there is for an IPO.
For mainboard IPOs, the subscription period lasts for 3 working days, while SME IPOs remain open for a longer period of 4-5 working days.

Formula to calculate Subscription Status:

Subscription = (Total Number of Bids Received) ÷ (Total Number of Shares Offered)

Day-Wise Subscription Table

Day

QIB

NII

Retail

Total Subscription

Day 1

NA

NA

NA

NA

Day 2

NA

NA

NA

NA

Day 3

NA

NA

NA

NA

Additional Read: How to Apply for Accretion Pharmaceuticals IPO?

How to Check IPO Subscription Data?

To keep track of the IPO's demand, follow these steps to track bids on both the NSE and BSE platforms:

Check out the following steps to track bids on NSE:

  1. Visit the NSE India website.

  2. Click on “IPO” and find Accretion Pharmaceuticals IPO.

  3. Click on NSE Bid Details or Consolidated Bid Details from the drop-down menu under Category.

Check out the following steps to track bids on BSE:

  • Go to the BSE India website.

  • Look for Accretion Pharmaceuticals IPO.

  • Click on BSE Bid Details or Cumulative Bid Details.

Conclusion

The Accretion Pharmaceuticals IPO offers a unique investment opportunity in a rapidly growing pharmaceutical company with a diverse product portfolio and a strong presence in global markets. The company’s robust infrastructure, ISO certifications, and expanding international reach position it well for future growth. However, potential investors should carefully consider the risks associated with its reliance on contract manufacturing and the SME listing platform, which may impact liquidity. With the IPO's opening date approaching, interested investors should stay informed about the subscription status and make decisions based on their investment goals and risk tolerance. For the final allotment details and status, check out the Accretion Pharmaceuticals IPO Allotment Status page.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Accretion Pharmaceuticals IPO.

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|